Literature DB >> 11161388

The clinical significance of MMP-1 expression in oesophageal carcinoma.

K Yamashita1, M Mori, A Kataoka, H Inoue, K Sugimachi.   

Abstract

Matrix metalloproteinase-1 (MMP-1) is involved in the degradation of interstitial collagen and thus thought to play a role in invasion of carcinoma. We investigated 51 oesophageal carcinoma patients to clarify the significance of MMP-1. MMP-1 mRNA was demonstrated to be expressed exclusively in almost all carcinoma tissue specimens (T) (94.1%) by reverse transcription-polymerase chain reaction, but not found in normal mucosal tissue specimens (N). The mean T/N ratio of MMP-1 was 42.5 and cases with T/N > or = 10 had a higher incidence of cases involving muscularis propria than those with T/N < 10 which included all the cases involving the submucosa (P< 0.05). MMP-1 mRNA was significantly associated with both 40 kD (putative active MMP-1) and 50 kD (putative latent MMP-1) gelatinolytic bands (n = 17). These findings indicated that MMP-1 mRNA reflected the net function of MMP-1 and suggested MMP-1 to be involved in carcinoma invasive process. On the other hand, MMP-1 mRNA was inversely correlated with the patient prognosis (P< 0.01). These results indicated that MMP-1 might therefore play a crucial role in local invasion, but not in systemic dissemination. As a result, MMP-1 might be a novel prognostic factor independent from those previously reported in oesophageal carcinoma. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161388      PMCID: PMC2363710          DOI: 10.1054/bjoc.2000.1568

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  35 in total

1.  Analysis of MT1-MMP and MMP2 expression in human gastric cancers.

Authors:  M Mori; K Mimori; T Shiraishi; T Fujie; K Baba; H Kusumoto; M Haraguchi; H Ueo; T Akiyoshi
Journal:  Int J Cancer       Date:  1997-06-20       Impact factor: 7.396

2.  Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

Authors:  C L Wilson; K J Heppner; P A Labosky; B L Hogan; L M Matrisian
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.

Authors:  T Yoshizaki; H Sato; Y Maruyama; S Murono; M Furukawa; C S Park; M Seiki
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

4.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

Authors:  A Okada; J P Bellocq; N Rouyer; M P Chenard; M C Rio; P Chambon; P Basset
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Interstitial collagenase gene expression in colonic neoplasia.

Authors:  S T Gray; K Yun; T Motoori; Y M Kuys
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

6.  Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer.

Authors:  G I Murray; M E Duncan; P O'Neil; W T Melvin; J E Fothergill
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

7.  Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer.

Authors:  M Mori; G F Barnard; R J Staniunas; J M Jessup; G D Steele; L B Chen
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

8.  Elongation factor 1 gamma mRNA expression in oesophageal carcinoma.

Authors:  K Mimori; M Mori; H Inoue; H Ueo; K Mafune; T Akiyoshi; K Sugimachi
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

9.  Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

Authors:  C F Sier; F J Kubben; S Ganesh; M M Heerding; G Griffioen; R Hanemaaijer; J H van Krieken; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

10.  Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect.

Authors:  S Takeha; Y Fujiyama; T Bamba; T Sorsa; H Nagura; H Ohtani
Journal:  Jpn J Cancer Res       Date:  1997-01
View more
  17 in total

1.  Inactivation of Rb in stromal fibroblasts promotes epithelial cell invasion.

Authors:  Adam Pickard; Ann-Christin Cichon; Anna Barry; Declan Kieran; Daksha Patel; Peter Hamilton; Manuel Salto-Tellez; Jacqueline James; Dennis J McCance
Journal:  EMBO J       Date:  2012-05-29       Impact factor: 11.598

2.  Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma.

Authors:  Zhen-Dong Gu; Ke-Neng Chen; Ming Li; Jin Gu; Ji-You Li
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

3.  Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers.

Authors:  D G Power; D H Ilson
Journal:  Ther Adv Med Oncol       Date:  2009-11       Impact factor: 8.168

4.  Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.

Authors:  S Samantaray; R Sharma; T K Chattopadhyaya; S Datta Gupta; R Ralhan
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-16       Impact factor: 4.553

Review 5.  In vivo cancer biomarkers of esophageal neoplasia.

Authors:  Shaoying Lu; Thomas D Wang
Journal:  Cancer Biomark       Date:  2008       Impact factor: 4.388

6.  Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion.

Authors:  Safinur Atay; Samagya Banskota; Jennifer Crow; Geetika Sethi; Lori Rink; Andrew K Godwin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

7.  Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma.

Authors:  Xiao-Li Du; Hai Hu; De-Chen Lin; Shu-Hua Xia; Xiao-Ming Shen; Yu Zhang; Man-Li Luo; Yan-Bin Feng; Yan Cai; Xin Xu; Ya-Ling Han; Qi-Min Zhan; Ming-Rong Wang
Journal:  J Mol Med (Berl)       Date:  2007-02-22       Impact factor: 5.606

8.  MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status.

Authors:  Martin Grimm; Maria Lazariotou; Stefan Kircher; Luisa Stuermer; Christoph Reiber; Andreas Höfelmayr; Stefan Gattenlöhner; Christoph Otto; Christoph T Germer; Burkhard H A von Rahden
Journal:  J Transl Med       Date:  2010-10-14       Impact factor: 5.531

9.  The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma.

Authors:  Richard Keld; Baoqiang Guo; Paul Downey; Christian Gulmann; Yeng S Ang; Andrew D Sharrocks
Journal:  Mol Cancer       Date:  2010-12-09       Impact factor: 27.401

10.  The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.

Authors:  A Hettiaratchi; N J Hawkins; G McKenzie; R L Ward; J E Hunt; D Wakefield; N Di Girolamo
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.